Navigation Links
SureSigns VS1 Vital Signs Monitor

ProductsSureSigns VS1 Vital Signs Monitor
Company Philips Medical Systems
Item SureSigns VS1 Vital Signs Monitor
Features 
  • Easy to use vital signs monitor.
  • Provides reliable, accurate, automated measurements in seconds.
  • Designed to make your job easier.
  • Large, bright, color-coded LED readings.
  • Proven measurement technologies.
  • Custom rollstand.
  • Available bar code scanner.
    • Description The new SureSigns VS1 is an easy to use vital signs monitor that provides reliable, accurate, automated measurements in seconds. The VS1 is designed to make your job easier, with features like large, bright, color-coded LED readings, proven measurement technologies, custom rollstand and available bar code scanner.
    Info Philips Medical SystemsCall Philips Medical Systems to buy products (US and Canada only; other locations use number below) USACanada1-866-745-0519

    Customer Service: 1-800-722-7900
    Web site: http://www.medical.philips.com/

    Related medicine products :

    1. SureSigns C1 Compact Patient Monitor
    2. M.R.I. Vital Port Systems (standard size)
    3. Titanium Vital Port Systems (standard size)
    4. Petite Titanium Vital Port Systems
    5. Petite M.R.I. Vital Port Systems
    6. Mini Titanium Vital Port Systems
    7. Dual Chamber M.R.I. Vital Port Systems
    8. Dual Chamber Titanium Vital Port Systems
    9. Petite Dual Chamber Titanium Vital Port Systems
    10. Mini Titanium Vital-Port Systems for Peripheral Placement
    11. Vitality DS
    The GC OIA test is a rapid assay for the diagnosis of gonorrhea. Thermo solved the challenge of developing a specific rapid assay for Neisseria gonorrhea by using the proprietary ribosomal protein,
    ...cceava Group A Strep test delivers excellent sensi...A Strep with a simple, easy-to-use test that provi...s value-added services enable you to provide impro...g requirements of waived laboratories. Find out wh...
    Neuroline monopolar needle electrodes are made of PTFE coated stainless steel and feature an ultra-sharp, conical tip, which ensures low friction at the point of insertion. This in turn, provides sig
    Shielding's Flex Back Apron is one of our most popular. Similar to the Velcro Adjustable but with elastic back panels for additional support and comfort.
    Medicine Products:
    (Date:9/5/2008)...s the Latest Developments in Molecular,Testing and... /PRNewswire-USNewswire/ -- The practice of,pathol...g and the promise,of personalized medicine will ch...and other imaging technologies will change the way...ogists is taking a leadership role in,making sure ...
    (Date:9/5/2008)...RNewswire-USNewswire/ -- The Health Resources,and ... million in grants to,increase and improve medical... grants continue President Bush,s historic expansi...w reach more economically,vulnerable and geographi...dministrator Elizabeth M. Duke said. "In 2007, mor...
    (Date:9/5/2008)...tical ,anti-cloak, could bring objects out of hidi...-- Just in case someone develops a cloak of invisi... how to uncloak the objects it hides. , Accordi...in materials underneath an invisibility cloak woul...esearchers at Shanghai Jiao Tong University in Chi...
    (Date:9/5/2008)...ain to commit to develop a National AIDS,Strategy ...p. 5 /PRNewswire-USNewswire/ -- The,Republican Nat...ion of the,domestic AIDS epidemic in the United St...erseas. Neither Presidential nominee Sen. John McC... mentioned AIDS in their remarks,to Convention del...
    Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 3
    ...morning-after pills to teenagers.This was revealed...e campaign has neither reduced conception nor abor...accused of fuelling record levels of sexually tran... it has been reported that the Government has spen...
    ...Adults Cannot Manage Without Cell Phones.The resea...ire in Stoke-on-Trent, who had conducted the resea...tive behavior when it comes to their cell phones. ...bile phones, he observed that some of the behavior...
    ...ughlin launched Children’s Hospice Week in the UK ... of the work hospices do as well as aid in the rai...nal experience to speak from. Her eight-year-old s...order Rett Syndrome and is a regular visitor to Cl...
    ...nvironmental changes have caused drastic increase ... 17% of the childhood cancer cases.// 77,111 case...97 in 15 European countries were analyzed in the s...s an increase by an average of 1.1% a year in the ...
    Other Medicine News:Health News:Government Failed to Prevent Rising Teen Pregnancies 2Health News:Government Failed to Prevent Rising Teen Pregnancies 3Health News:17 percent rise in childhood cancer cases due to modern lifestyles 2
    (Date:9/5/2008)...d From a Simple Blood Draw Have,the Potential to S...ange of Indications,U... is Currently Developing a Blood-Bas...nd JERSEY CITY, New Jersey, September 5,/PRNewswir...G), a leader in,the development of microRNA-based ...
    (Date:9/4/2008)...FirstCall/ -- BioForm Medical,Inc. (Nasdaq: BFRM... of,Polidocanol, conducted in Germany by BioForm M... GmbH (Kreussler), successfully met the study prim... of a New Drug Application,(NDA) process., In the...and safety of,Aethoxysklerol compared to Sodium Te...
    (Date:9/4/2008)...cologists States UFE Meets Level,A Evidence for Cl...tional,Radiology Treatment Is Safe, Effective Opti... Sept. 4 /PRNewswire-USNewswire/ -- The Society of... of nearly 4,500 doctors,scientists and allied he...are through minimally invasive treatment intervent...
    (Date:9/4/2008)...swire/ -- Axentis Pharma AG has,initiated a clinic...bility,of a new therapeutic formulation for the tr...brosis patients. The new formulation allows an,est...y to the site of,infection. The forthcoming trial ...es of the new drug. Initial results are expected i...
    Breaking Medicine Technology:Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 2Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 3Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 4338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 2338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 4338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 5Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 2Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Research to lead to brain tumor therapies 14921 1Research to lead to brain tumor therapies 14921 2Research to lead to brain tumor therapies 14921 3Finesse Introduces TruFluor 28TM 29 DO a Single Use Optical Dissolved Oxygen Sensor and Transmitter 4136 1Finesse Introduces TruFluor 28TM 29 DO a Single Use Optical Dissolved Oxygen Sensor and Transmitter 4136 2Free drug samples may burden patients pockets 14918 1Free drug samples may burden patients pockets 14918 2Free drug samples may burden patients pockets 14918 3Therapeutic cloning treats Parkinsons disease in mice 14916 1
    ...International Symposium on,Myelodysplastic Syndrom...updated results,from a pivotal Phase II trial eval...d cancer known as myelodysplastic syndromes (MDS),... Lee Moffitt,Cancer Center & Research Institut...ntly taking place in Florence, Italy.,Breakthrough...
    ...2007 /PRNewswire-FirstCall/ -,MIGENIX Inc. , a cli...ases will make a presentation of results from a re...y (see April 11, 2007,press release) in a non-resp... (DDW) 2007 being held in Washington, DC May 19-24... Hepatitis,Investigative Unit (VHIU) at the Health...
    Other Medicine Technology:Study Continues to Show Patients With Myelodysplastic Syndromes,Treated With Revlimid are Living Longer and Remaining Transfusion,Independent 2Study Continues to Show Patients With Myelodysplastic Syndromes,Treated With Revlimid are Living Longer and Remaining Transfusion,Independent 3Migenix to Present Celgosivir Phase II Hepatitis C Results at,Digestive Disease Week 2007 2Migenix to Present Celgosivir Phase II Hepatitis C Results at,Digestive Disease Week 2007 3